Emalex.
Edit

Emalex.

https://emalexbiosciences.com/
Last activity: 03.01.2023
Categories: DevelopmentMedtechResearch
Developing new treatments for rare and orphan neurological conditions.
Mentions
12
Location: United States, Illinois, Chicago
Total raised: $285M

Investors 3

Funding Rounds 2

DateSeriesAmountInvestors
04.11.2022Series D$250M-
23.03.2021Series C$35M-

Mentions in press and media 12

DateTitleDescriptionSource
03.01.2023This biotech founder has a new plan to treat Tourette Syndro...Jeff Aronin, CEO of Paragon Biosciences and founder of Emalex Biosciences. Paragon Biosciences Emal...businessin...
04.11.2022Emalex Biosciences Raises $250M in Series D Financing RoundEmalex Biosciences, a Chicago, IL-based biotechnology company, raised $250M in Series D funding. Th...finsmes.co...
03.11.2022Bain Capital-Backed Emalex Bio Lands $250M for Pivotal Test ...Tourette syndrome causes involuntary muscle and vocal tics that can be treated with several drugs, b...medcitynew...
03.11.2022Emalex Biosciences Announces $250M Series D CHICAGO, IL, Emalex Biosciences announced the closing of an upsized and oversubscribed $250 millio...vcnewsdail...
03.11.2022Emalex Raises $250M For Tourette Syndrome Treatment4 Shares Email Facebook Twitter LinkedIn Not all late-stage companies are feeling the funding droug...news.crunc...
23.03.2021Emalex Biosciences Raises $35M in Series C FundingEmalex Biosciences, Inc., a Chicago, IL-based biopharmaceutical company founded to develop treatment...finsmes.co...
23.03.2021Emalex Biosciences Raises $35 Million in Series C Preferred ... CHICAGO, March 23, 2021 /PRNewswire/ -- Emalex Biosciences, Inc. ("Emalex"), a biopharma...prnewswire...
23.03.2021Emalex Biosciences Scoops Up $35M Series C CHICAGO, IL, Emalex Biosciences today announced $35 million in Series C Preferred Stock funding. ...vcnewsdail...
23.03.2021Jeff Aron­in's Emalex rais­es $35M Se­ries C; British pro­te...Jeff Aronin has a new raise in place for one of his port­fo­lio com­pa­nies. Emalex Bio­sciences is...endpts.com...
-Emalex Biosciences, Inc.“Developing new treatments for rare and orphan neurological conditions.”fastfounde...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In